Literature DB >> 29929669

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.

Carole Maupain1, Nicolas Badenco2, Françoise Pousset1, Xavier Waintraub2, Guillaume Duthoit2, Thomas Chastre2, Caroline Himbert2, Jean-Louis Hébert2, Robert Frank2, Françoise Hidden-Lucet1, Estelle Gandjbakhch3.   

Abstract

OBJECTIVES: The purpose of this study was to identify clinical factors associated with arrhythmic events and sudden cardiac death (SCD), and to evaluate the prognostic value of electrophysiological study (EPS) in arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) patients without implantable cardioverter-defibrillators (ICDs).
BACKGROUND: ARVC/D is an inherited cardiomyopathy characterized by a risk of SCD. Few studies have evaluated predictive factors of ventricular arrhythmias (VAs) in patients without ICDs.
METHODS: Between 2000 and 2010, all consecutive patients with ARVC/D without ICDs and with EPS at diagnosis were enrolled. Patients that received an ICD during follow-up were censored at the date of implantation, and in that case, only VAs that occurred before ICD implantation were analyzed. Risk factors for any VA event were determined by Cox regression. Patients that only experienced SCD or aborted cardiac arrest (ACA) were reported.
RESULTS: A total of 137 consecutive patients (78% male) diagnosed with ARVC/D without ICD were enrolled. 31% had sustained ventricular tachycardia at diagnosis. After mean follow-up of 42 ± 31 months, 19 patients experienced an episode of sustained VA and 5 patients experienced a SCD/ACA. No event occurred in asymptomatic patients. Left ventricular ejection fraction ≤50% (p = 0.024), positive EPS (p = 0.017), and physical activity >6 h/week (p = 0.025) were independently associated with occurrence of VAs. SCD/ACA exclusively occurred in male probands with definite diagnosis and syncope.
CONCLUSIONS: In this cohort of ARVC/D patients without ICD, left ventricular ejection fraction ≤50%, positive EPS, and physical activity >6 h/week were independent predictors of VAs, whereas asymptomatic patients at diagnosis were at low risk. EPS predicted all VAs but had limited value to predict SCD/ACA.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arrhythmogenic right ventricular cardiomyopathy/dysplasia; electrophysiological study; risk stratification; sudden cardiac death; ventricular arrhythmia

Mesh:

Year:  2018        PMID: 29929669     DOI: 10.1016/j.jacep.2018.04.017

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  3 in total

Review 1.  Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Ryan Wallace; Hugh Calkins
Journal:  Arrhythm Electrophysiol Rev       Date:  2021-04

2.  Ventricular arrhythmia management in patients with genetic cardiomyopathies.

Authors:  Zain I Sharif; Steven A Lubitz
Journal:  Heart Rhythm O2       Date:  2021-12-17

3.  Machine learning techniques for arrhythmic risk stratification: a review of the literature.

Authors:  Cheuk To Chung; George Bazoukis; Sharen Lee; Ying Liu; Tong Liu; Konstantinos P Letsas; Antonis A Armoundas; Gary Tse
Journal:  Int J Arrhythmia       Date:  2022-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.